RSS News

Pharmaceutical Industry

Drugs Licensed

Drugs approved for other diseases may unlock a faster path to Alzheimer’s treatment, UNLV researcher says - KLAS - 8 News Now

Proposed legislation paves the way for AI to prescribe drugs - Mobihealth News

It’s not just AI. China’s medicines are surprising the world, too - The Economist

Synthetic Approaches to the New Drugs Approved during 2023 - ACS Publications

Drugs approved for other diseases may unlock a faster path to Alzheimer’s treatment, UNLV researcher says - KLAS - 8 News Now

Bill would allow AIs to prescribe FDA-approved drugs - pharmaphorum

National Drug Code Directory - FDA.gov

Oncology Drugs Approved by the FDA in January 2025 - www.oncnursingnews.com/

Six new drugs approved for NHS use in Scotland - BBC.com

Drugs Patents

5 Pharma Powerhouses Facing Massive Patent Cliffs—And What They’re Doing About It - BioSpace

Unravelling the challenge of AI inventorship in healthcare - Drug Discovery & Development

Drug Patent and Exclusivity Study available - United States Patent and Trademark Office

USPTO Confirms Unreliable Patent Numbers by I-MAK in Drug Pricing Debate - Hudson Institute

WVU legal scholar makes case for equal protection among different medication classes - WVU Today

The Economics of Drug Discovery and the Impact of Patents - R Street

Sponsored Content: The Connection Between Patents and High Drug Prices - POLITICO

Axsome secures top drug’s future with Teva patent settlement - BioPharma Dive

RAI Explainer: Generic Drugs, Property Rights, and the Orange Book - Center for Strategic & International Studies

Drugs Generics

All generic drugs are not equal, study finds - The Ohio State University News

Trump’s Tariffs Prompt Fears for Cost, Quality of Critical Medications | Healthiest Communities Health News | U.S. News - U.S. News & World Report

Stabilising Europe’s generic medicine supply - European Pharmaceutical Review

'Ineffective' generic drugs fuel rare public anger in China - BBC.com

Generic Drugs Forum (GDF) 2024: Regulatory Considerations to Enhance Generic Drug Access - FDA.gov

China's health regulator defends quality of local generic drugs - Reuters

RAI Explainer: Generic Drugs, Property Rights, and the Orange Book - Center for Strategic & International Studies

Industrial Policy To Reduce Prescription Generic Drug Shortages - Center For American Progress

Gen Z’s expensive drug habit: More want brand-name meds that are 79% more expensive - Fortune

FDA Food and Drug Administration

Trump administration cuts reach FDA employees in food safety, medical devices and tobacco products - The Associated Press

Ozempic and Wegovy are no longer in shortage, FDA says - CNN

Deputy director of FDA’s CBER departs amid mass exodus at federal health agencies - Fierce Biotech

FDA Continues Push to Improve Food Labeling Practices in the United States - The National Law Review

FDA declares semaglutide shortage over, spelling end to compounded GLP-1 market - Fierce healthcare

FDA’s food safety head resigns over mass layoffs - The Hill

Exclusive: FDA staffers told that 'woman,' 'disabled' among banned words; White House says it’s an error - Reuters

With RFK Jr. in charge, supplement makers see chance to cash in - CBS News

FDA cuts, zombie biotechs, and too much weight loss? - STAT

Pharmaceutical Companies

Drug industry sees partnership with Trump, RFK Jr. - Axios

Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women’s Health and Dermatology - Business Wire

Exposing an Indian pharma firm fuelling West Africa's opioid crisis - BBC.com

Indian drugmakers can retain US dominance even with tariffs, says industry body - Reuters

Long COVID studies stymied by pharma’s lack of cooperation - Chemical & Engineering News

How Donald Trump’s tariff on pharmaceuticals could cause headaches for American patients and Canadian companies - Edmonton Journal

Cosette sets sights on women's healthcare stardom with $430M Mayne Pharma buy - FiercePharma

Navigating the Complexities of Sustainable Specialty Pharma Supply Chains - Clinical Trials Arena

Amazon joins forces with Memorial Sloan Kettering for AI-powered drug discovery - Pharmaceutical Technology

Retail Pharmacies

Big Y Appoints Director of Pharmacy - Progressive Grocer

TRICARE Changes Could Affect Service Members’ Access to Pharmacies: Report - NGAUS

An alarming trend: Ohio pharmacy closures spike, openings lag - Ohio Capital Journal

CVS Stock Is Soaring. A Director Bets $2 Million on the Rally. - Barron's

With Retail Pharmacies Under The Weather, CRE Grapples For The Right Prescription - Bisnow

TRICARE Changes Could Affect Military Servicemembers’ Access to Pharmacies - Government Accountability Office

Why community pharmacies are closing – and what to do if your neighborhood location shutters - theconversation.com

Nearly 1 in 3 retail pharmacies have closed since 2010 - UC Berkeley School of Public Health

Kroger & Walmart expect GLP-1 drugs to grow pharmacy sales but hurt grocery - Modern Retail

Drug Marketing

China Issues New Domestic Responsible Person Rules for Foreign Drug Marketing Authorization Holders - Morgan Lewis

National Drug Code Directory - FDA.gov

Moderna, Novo Nordisk slammed for breaching UK drug marketing code yet again - FiercePharma

The multiple myeloma drug market - Nature.com

Prescription Drug Costs | Pros, Cons, Debate, Arguments, Economy, Laws, Government, & Regulation - Britannica

Prescription drug expenditure in the U.S. 1960-2024 - Statista

Evaluation of Companion Diagnostics in Scientific Advice and Drug Marketing Authorization Applications by the European Medicines Agency - Frontiers

Robert F. Kennedy Jr. Wants to Ban Drug Ads on TV. It Wouldn’t Be Easy. - The New York Times

Drug Discovery Market Is Expected To Reach RevenueOf USD - GlobeNewswire